Japan AI Healthcare Stocks With High Returns And Low P E Ratios

Transformative AI healthcare stocks sit at the intersection of two powerful forces. Global data shows central banks are cautious, inflation trends are mixed, and borrowing costs are pressuring housing and consumers. In this kind of backdrop, many investors look for themes tied to long term structural change rather than short term cycles. AI in healthcare fits that brief. It aims to improve accuracy, reduce waste, and support better outcomes. This article highlights three stocks from the Transformative AI Healthcare screener that show how this theme is playing out across diagnostics, treatment and care delivery.

ASO International (TSE:9340)

Overview: ASO International is a Japan based dental orthodontics company that provides a wide range of specialist products and services, from lingual and clear aligner systems to 3D printers, AI enabled scanning tools and digital modeling for clinics and labs.

Market Cap: ¥7.0b

ASO International gives you exposure to the digital transformation of orthodontic care, with a mix of physical appliances and software tools such as AI supported WE SCAN and ASO Digital 3D printing services. According to one internal DCF, the stock currently trades below an independent estimate of fair value, while its P/E is under both peer and industry averages. Earnings growth has been steady rather than rapid and margins are solid, although there has been slight pressure on profit margins and return on equity is expected to stay moderate. Governance is the main watchpoint, with no independent directors and a reliance on external borrowing that raises questions careful investors may want to consider.

ASO International’s steady earnings and below sector P/E suggest the market may be missing something. See how the DCF valuation analysis for ASO International ties together the valuation gap and the governance question lurking in the background.

eWeLLLtd (TSE:5038)

Overview: eWeLLLtd runs a suite of cloud tools that power home based medical and nursing care in Japan, from electronic medical records and insurance claim systems to attendance management, AI supported visit reporting, factoring services and e learning for visiting nurses.

Operations: eWeLLLtd currently generates all of its ¥3,592 million in revenue from providing services to home visit nursing stations.

Market Cap: ¥31.6b

eWeLLLtd sits in the middle of the shift toward home based care, with its iBow platform handling functions such as clinical records, billing and workforce management. The company reports high margins and a 36% return on equity. At the same time, it relies on higher risk external borrowings to fund its balance sheet, governance independence is limited and the share price has lagged the wider Japanese market over the period described. For investors who want to understand whether the current valuation and recent buybacks and dividend increases adequately reflect these trade offs, the full story may merit closer examination.

eWeLLLtd’s high margins and 36% return on equity suggest there may be more to the story than the wider market has currently recognized. Read the analysis report for eWeLLLtd to see what the debt mix and capital returns might be masking.

FINDEX (TSE:3649)

Overview: FINDEX is a Japan based healthtech company that supplies software and devices to hospitals and clinics, including electronic medical records, image and document management, diagnostic support tools and AI assisted medical text generation.

Operations: FINDEX generates around ¥5,771.8 million from its Medical Business, ¥268.4 million from Public Sector Business and ¥108.0 million from Health Tech Business, almost all of it in Japan.

Market Cap: ¥21.1b

FINDEX sits at the heart of hospital IT in Japan, with a product suite that ties together imaging, records, diagnostics and AI based documentation. Earnings are described as high quality, margins are healthy with a net profit margin of 20.2%, and return on equity of 22.3% points to efficient use of capital. Forecast earnings growth of 14.72% a year is expected to outpace the broader Japanese market, yet the stock trades on a P/E below both peers and the wider healthcare services group and at a discount to one cash flow based fair value estimate. The main counterpoints are higher funding risk due to reliance on external borrowing and some gaps in disclosure around management and board structure, which are important for you to weigh against the growth story.

FINDEX combines high quality earnings, a 20.2% net margin and 22.3% return on equity with a P/E below peers and some cash flow based fair value estimates. Get the full context in the DCF valuation analysis for FINDEX, where one detail could flip how you see its risk reward balance.

The three stocks in this article are only a starting point, since the full screen of transformative AI healthcare opportunities surfaced 3 more companies with equally compelling narratives in the Transformative Artificial intelligence (AI) Healthcare Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter most to you so you can focus on the highest conviction ideas in this space.

Take Control of Your Investment Journey

If eWeLLLtd or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Beyond AI Healthcare

Fresh stock ideas can move quickly once momentum builds and prices start flying. Use these focused lists before the crowd catches on and the entry window starts dropping; act now.

• Capture potential turnarounds in smaller companies by scanning the 1 elite penny stocks with strong financials, which pair higher risk with stronger balance sheets and cleaner financials than many typical micro caps.
• Ride the long term infrastructure shift by reviewing the 34 power grid technology and infrastructure stocks, featuring companies tied to grid reliability, transmission upgrades and the systems that keep electricity flowing when demand spikes.
• Position ahead of commodity momentum by checking the 32 elite gold producer stocks, which highlights producers with scale, direct exposure to bullion prices and business models built around extraction, not speculation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com